EP1360961 - Use of antimicrobial peptides for potentiating the activity of antimicrobial agents [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.01.2005 Database last updated on 31.08.2024 | Most recent event Tooltip | 21.01.2005 | Application deemed to be withdrawn | published on 09.03.2005 [2005/10] | Applicant(s) | For all designated states AM-Pharma B.V. Prof. Bronckhorstlaan 10 3723 MB Bilthoven / NL | [2003/46] | Inventor(s) | 01 /
Nibbering, Petrus, Hendricus 5, Chopinlaan 2215 SL Voorhout / NL | 02 /
Lupetti, Antonella 27, Viale Giobanni Pisano 56100 Pisa / IT | [2003/46] | Representative(s) | Wittop Koning, Tom Hugo, et al Exter Polak & Charlouis B.V. (EP&C) P.O. Box 3241 2280 GE Rijswijk / NL | [N/P] |
Former [2003/46] | Wittop Koning, Tom Hugo, et al Exter Polak & Charlouis B.V., P.O. Box 3241 2280 GE Rijswijk / NL | Application number, filing date | 02076804.0 | 07.05.2002 | [2003/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1360961 | Date: | 12.11.2003 | Language: | EN | [2003/46] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.03.2003 | Classification | IPC: | A61K38/08, A61K38/10, A61K38/16, A61K31/41, A61K31/00 | [2003/46] | CPC: |
A61K38/10 (EP);
A61K38/08 (EP,US);
A61K38/1709 (EP);
A61K38/40 (EP)
| C-Set: |
A61K38/08, A61K2300/00 (EP);
A61K38/08, A61K31/41 (EP);
A61K38/10, A61K2300/00 (EP);
A61K38/10, A61K31/41 (EP);
A61K38/16, A61K31/41 (EP);
A61K38/1709, A61K2300/00 (EP); | Designated contracting states | (deleted) [2004/32] |
Former [2003/46] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Title | German: | Verwendung von antimikrobiell wirkenden Peptiden zur Aktivitätssteigerung von antimikrobiellen Wirkstoffen | [2003/46] | English: | Use of antimicrobial peptides for potentiating the activity of antimicrobial agents | [2003/46] | French: | Utilisation de peptides antibiotiques pour potentialiser l'activité des agents antimicrobiens | [2003/46] | Examination procedure | 13.05.2004 | Application deemed to be withdrawn, date of legal effect [2005/10] | 24.09.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2005/10] | Fees paid | Penalty fee | Penalty fee Rule 85a EPC 1973 | 07.07.2004 | AT   M01   Not yet paid | 07.07.2004 | BE   M01   Not yet paid | 07.07.2004 | CH   M01   Not yet paid | 07.07.2004 | CY   M01   Not yet paid | 07.07.2004 | DE   M01   Not yet paid | 07.07.2004 | DK   M01   Not yet paid | 07.07.2004 | ES   M01   Not yet paid | 07.07.2004 | FI   M01   Not yet paid | 07.07.2004 | FR   M01   Not yet paid | 07.07.2004 | GB   M01   Not yet paid | 07.07.2004 | GR   M01   Not yet paid | 07.07.2004 | IE   M01   Not yet paid | 07.07.2004 | IT   M01   Not yet paid | 07.07.2004 | LU   M01   Not yet paid | 07.07.2004 | MC   M01   Not yet paid | 07.07.2004 | NL   M01   Not yet paid | 07.07.2004 | PT   M01   Not yet paid | 07.07.2004 | SE   M01   Not yet paid | 07.07.2004 | TR   M01   Not yet paid | Penalty fee Rule 85b EPC 1973 | 07.07.2004 | M01   Not yet paid | Additional fee for renewal fee | 31.05.2004 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]JPH092970 ; | [X]WO9012587 (MAGAININ SCIENCES INC [US]) [X] 1 * abstract * * page 3, paragraph 2 - page 4, paragraph 3 * * page 5, paragraph 2 * * page 6, paragraph 2 * * page 6, paragraph 4 - page 7, paragraph 1 * * page 12, paragraph 4 - page 15, paragraph 1 * * page 25, line 7 - page 26, line 2 * * page 31, line 1 - page 32, line 6 * * claims 1,19,22 *; | [DX]EP0629347 (MORINAGA MILK INDUSTRY CO LTD [JP]) [DX] 1-8,10-15 * page 5, line 4 - page 6, line 47 * * page 41, sequence no. 30;; page 24, line 37 - line 41 *; | [X]WO9638163 (BIOSYNTH SRL [IT]) [X] 1 * claims 1,3 * * abstract * * page 1, line 24 - page 2, line 19 * * page 3, line 21 - page 4, line 5 * * page 22, line 8 - line 18 *; | [X]WO9840401 (MICROLOGIX BIOTECH INC [CA], et al) [X] 1 * abstract * * page 6, line 15 - page 15, line 2 * * page 20, paragraph 4 - page 25, paragraph 1 * * page 25, paragraph 4 - page 33 * * tables 1-6 * * claims 1,12-14,18-20,25,26,28-34 *; | [DX]WO0134641 (PHARMING INTELLECTUAL PTY BV [NL], et al) [DX] 1-15 * page 6, line 9 - line 22 * * page 13, line 26 - line 30 * * page 14, line 4 - line 13 * * page 26, line 28 - line 33 * * page 27, line 6 - line 8 * * page 29, line 28 - line 34 * * claims 1,7,12,16 * * figures 2B,3C *; | [Y]WO0172322 (PHARMING INTELLECTUAL PTY BV [NL], et al) [Y] 1-15 * page 3, line 25 - line 27 * * page 6, line 12 - line 13 * * page 6, line 23 - line 25 *; | [X] - VAN'T HOF W, REIJNDERS IM, HELMERHORST EJ, WALGREEN-WETERINGS E, SIMOONS-SMIT IM, VEERMAN ECI, NIEUW AMERONGEN AV, "Synergistic effects of low doses of histatin5 and its analogues on amphotericin B anti-mycotic activity", ANTONIE VAN LEEUWENHOEK, (2000), vol. 78, no. 2, pages 163 - 169, XP008010102 [X] 1 * abstract * * page 164, column R, paragraph 2 * * page 164, column R, paragraph 4 - page 165, column L, paragraph 1 * * page 165, column L, paragraph 3 * * page 166, column L, paragraph 2 - column R, paragraph 2 * * tables 1-3 * DOI: http://dx.doi.org/10.1023/A:1026572128004 | [X] - MARTTI VAARA ET AL, "Group of Peptides That Act Synergistically with Hydrophobic Antibiotics against Gram-Negative Enteric Bacteria", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (1996), vol. 8, no. 40, ISSN 0066-4804, pages 1801 - 5, XP002080197 [X] 1 * abstract * * page 1803, column R, paragraph 4 * * table 3 * | [X] - DARVEAU RP, CUNNINGHAM MD, SEACHORD CL, CASSIANO-CLOUGH L, COSAND EL, BLAKE J, WATKINS CS, ".beta.-Lactam Antibiotics Potentiate Magainin 2 Antimicrobial Activity In Vitro and In Vivo", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (199106), vol. 35, no. 6, pages 1153 - 1159, XP008010120 [X] 1 * abstract * * page 1154, column L, paragraph 1 * * page 1158, column L, paragraph 4 * | [X] - HANCOCK R E W, "Peptide antibiotics", THE LANCET, (1997), vol. 349, pages 418 - 422, XP002219723 [X] 1-15 * page 418, column L, paragraph 4 - column R, paragraph 4 * * page 419, column R * * page 420, column L, paragraph 1 * * page 421, column L, paragraph 2 * DOI: http://dx.doi.org/10.1016/S0140-6736(97)80051-7 | [Y] - LUPETTI, ANTONELLA ET AL, "Candidacidal activities of human lactoferrin peptides derived from the N terminus", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000), 44(12), 3257-3263, XP002219724 [Y] 1-15 * abstract * * page 3257, column R, line 5 - line 12 * * page 3258, line 4 - line 11 * * page 3258, column R, paragraph 7 - page 3259, column L, paragraph 1 * * page 3262, column L, line 34 - column R, line 11 * DOI: http://dx.doi.org/10.1128/AAC.44.12.3257-3263.2000 | [Y] - DATABASE WPI, 1, Derwent World Patents Index, vol. 1997, no. 11, Database accession no. 1997-115216, XP002219725 & JPH092970 A 19970107 (MORINAGA MILK IND CO LTD) [Y] 1-15 * abstract * |